Key result
Surgery and chemotherapy achieve disease-free recovery in a pulmonary artery sarcoma case.
Why the study?
Pulmonary artery sarcoma is a rare tumor that is easily misdiagnosed, often as pulmonary embolism, leading to challenges in appropriate management.
Case Report (n=1)
Multimodal therapy including surgical resection and chemotherapy can provide prolonged survival in patients with pulmonary artery sarcoma, a rare tumor often misdiagnosed as pulmonary embolism.
Supports multimodal therapy consideration in pulmonary artery sarcoma; hypothesis-generating and should not yet change practice.
Pulmonary artery sarcoma is a rare type of tumor and is easily misdiagnosed. We report a case of pulmonary artery sarcoma in a 26-year-old young man who presented with acute onset of dyspnea. Computed tomographic angiography of the chest had revealed a large filling defect within the main pulmonary artery (PA) that extended into both right and left PAs. Because pulmonary embolism was suspected, both anticoagulant and thrombolytic therapies were initiated. The patient responded poorly to these therapies, leading to the resection of the mass. After an uneventful postoperative course, the patient was discharged from the hospital on postoperative day ten. He was subsequently treated with chemotherapy and continued to show no evidence of disease. Multimodal therapy can provide prolonged survival. O sarcoma da artéria pulmonar é um tumor raro, de diagnóstico difícil. Apresentamos um caso de sarcoma da artéria pulmonar num jovem de 26 anos que se manifestou por um quadro de dispneia aguda. A angiografia computadorizada do tórax revelou um extenso defeito de preenchimento no tronco da artéria pulmonar que se estendia para ambos os seus ramos. Devido à suspeita de embolia pulmonar, foi iniciada terapêutica anticoagulante e trombolítica. O doente respondeu mal a este tratamento tendo posteriormente sido efetuada a resseção da massa. O doente teve alta ao 10° dia pós-operatório, sem complicações. Foi posteriormente submetido a quimioterapia, sem recidiva da doença, revelando que a terapêutica multimodal pode prolongar a sobrevivência desta patologia.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) conducted a case report in Pulmonary artery sarcoma (n=1). Surgical resection and chemotherapy was evaluated on Survival and disease recurrence. Multimodal therapy including surgical resection and chemotherapy led to an uneventful recovery and no evidence of disease in a 26-year-old man with pulmonary artery sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: